BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1818089)

  • 1. Modeling and conformation analysis of beta-cyclodextrin complexes.
    Kostense AS; van Helden SP; Janssen LH
    J Comput Aided Mol Des; 1991 Dec; 5(6):525-43. PubMed ID: 1818089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crystal structure of the 1:1 inclusion complex of beta-cyclodextrin with squaric acid.
    Crisma M; Fornasier R; Marcuzzi F
    Carbohydr Res; 2001 Jul; 333(2):145-51. PubMed ID: 11448675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and modelling of the structures of beta-cyclodextrin complexes.
    Myles AM; Barlow DJ; France G; Lawrence MJ
    Biochim Biophys Acta; 1994 Jan; 1199(1):27-36. PubMed ID: 8280750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular structures of the inclusion complexes beta-cyclodextrin-1,2-bis(4-aminophenyl)ethane and beta-cyclodextrin-4,4'-diaminobiphenyl; packing of dimeric beta-cyclodextrin inclusion complexes.
    Giastas P; Yannakopoulou K; Mavridis IM
    Acta Crystallogr B; 2003 Apr; 59(Pt 2):287-99. PubMed ID: 12657820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular recognition in cyclodextrin complexes of amino acid derivatives. 2. A new perturbation: the room-temperature crystallographic structure determination for the N-acetyl-p-methoxy-L-phenylalanine methyl ester/beta-cyclodextrin complex.
    Clark JL; Booth BR; Stezowski JJ
    J Am Chem Soc; 2001 Oct; 123(40):9889-95. PubMed ID: 11583553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular recognition in cyclodextrin complexes of amino acid derivatives. 1. Crystallographic studies of beta-cyclodextrin complexes with N-acetyl-L-phenylalanine methyl ester and N-acetyl-L-phenylalanine amide pseudopeptides.
    Clark JL; Stezowski JJ
    J Am Chem Soc; 2001 Oct; 123(40):9880-8. PubMed ID: 11583552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of beta-cyclodextrin complexes with nootropic drugs.
    Amato ME; Djedaïni F; Pappalardo GC; Perly B; Scarlata G
    J Pharm Sci; 1992 Dec; 81(12):1157-61. PubMed ID: 1491330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between beta-cyclodextrin and 1,10-phenanthroline: uncommon 2:3 inclusion complex in the solid state.
    Liu Y; Chen GS; Zhang HY; Song HB; Ding F
    Carbohydr Res; 2004 Jun; 339(9):1649-54. PubMed ID: 15183740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral recognition of aromatic compounds by beta-cyclodextrin based on bimodal complexation.
    Cai W; Yu Y; Shao X
    J Mol Model; 2005 Jun; 11(3):186-93. PubMed ID: 15900481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A self-included cyclomaltoheptaose derivative studied by NMR spectroscopy and molecular modelling.
    Berthault P; Duchesne D; Desvaux H; Gilquin B
    Carbohydr Res; 1995 Oct; 276(2):267-87. PubMed ID: 8542602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conformational behaviour of complexes of alpha-cyclodextrin with p-chlorophenol and p-hydroxybenzoic acid in water as studied by molecular dynamics simulations.
    van Helden SP; van Eijck BP; Janssen LH
    J Biomol Struct Dyn; 1992 Jun; 9(6):1269-83. PubMed ID: 1637512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the complex of heptakis(2,6-di-O-methyl)-beta-cyclodextrin with (2,4-dichlorophenoxy)acetic acid.
    Tsorteki F; Mentzafos D
    Carbohydr Res; 2002 Jul; 337(13):1229-33. PubMed ID: 12110198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AM1 calculations on inclusion complexes of cyclomaltoheptaose (beta-cyclodextrin) with 1,7-dioxaspiro[5.5]undecane and nonanal, and comparison with experimental results.
    Botsi A; Yannakopoulou K; Hadjoudis E; Waite J
    Carbohydr Res; 1996 Mar; 283():1-16. PubMed ID: 8901259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-cyclodextrin inclusion complexes: effect of the host substitution on molecular recognition].
    Barczáné BA; Barcza L
    Acta Pharm Hung; 2000; 70(3-6):82-8. PubMed ID: 11379035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the complex of beta-cyclodextrin with beta-naphthyloxyacetic acid in the solid state and in aqueous solution.
    Kokkinou A; Yannakopoulou K; Mavridis IM; Mentzafo D
    Carbohydr Res; 2001 May; 332(1):85-94. PubMed ID: 11403091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular modelling study of the interaction between beta-cyclodextrin and the organophosphorothioate pesticide parathion.
    Manunza B; Deiana S; Pintore M; Gessa C
    Glycoconj J; 1998 Mar; 15(3):293-6. PubMed ID: 9579806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modelling of the inclusion complexes between beta-cyclodextrin and (R)/(S)-methylphenobarbitone and its application to HPLC.
    Durham DG; Liang H
    Chirality; 1994; 6(4):239-44. PubMed ID: 8068488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the inclusion complexes of heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin with indole-3-butyric acid and 2,4-dichlorophenoxyacetic acid.
    Tsorteki F; Bethanis K; Mentzafos D
    Carbohydr Res; 2004 Jan; 339(2):233-40. PubMed ID: 14698881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic analysis of the thermal motion of the inclusion complex of cyclomaltoheptaose (beta-cyclodextrin) with hexamethylenetetramine.
    Harata K
    Carbohydr Res; 2003 Feb; 338(4):353-9. PubMed ID: 12559733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo simulations of the chiral recognition of fenoprofen enantiomers by cyclomaltoheptaose (beta-cyclodextrin).
    Choi YH; Yang CH; Kim HW; Jung S
    Carbohydr Res; 2000 Sep; 328(3):393-7. PubMed ID: 11072846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.